Press Releases
Pint of Science returns bringing Warwick scientists out of the lab and into your living room
The public science festival, Pint of Science, kicks off next week with experts from the University of Warwick talking about their research live in your living room.
Using phage to discover new antifreeze proteins
Controlling, and mitigating the effects of ice growth is crucial to protect infrastructure, help preserve frozen cells and to enhance texture of frozen foods. An international collaboration of Warwick Scientists working with researchers from Switzerland have used a phage display platform to discover new, small, peptides which function like larger antifreeze proteins. This presents a route to new, easier to synthesise, cryoprotectants.
Funding for new research to deliver cleaner and greener chemicals
Researchers have been awarded funding to work with a global leader in the speciality chemicals industry to create cleaner and greener chemical processing methods for everyday products in a bid to help the government meet its carbon neutral targets.
University of Warwick Spin-Out, CryoLogyx, partners with investors
The University of Warwick spin-out company, CryoLogyx, has received a further investment from Oxford Technology Management and private investors, alongside £300k from InnovateUK.
Solving the puzzle of polymers binding to ice for Cryopreservation
When biological material (cells, blood, tissues) is frozen, cryoprotectants are used to prevent the damage associated with the formation of ice during the freezing process. New polymeric cryoprotectants are emerging, alongside the established cryoprotectants, but how exactly they manage to control ice formation and growth is still largely unknown. This is especially true for PVA, a deceptively simple synthetic polymer that interacts with ice by means of mechanisms that have now been revealed at the atomistic level thanks to researchers from the University of Warwick.
Scientists able to see how potential cancer treatment reacts in single cell
Using a 185 metre beamline at the Diamond synchrotron, researchers could see how Osmium, a rare precious metal that could be used for cancer treatments, reacts in a single human lung cancer cell. This is a major step forward in discovering new anti-cancer drugs for researchers at the University of Warwick.